These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2865924)

  • 41. [Heroin addiction].
    Biron A
    Soins; 1977 Dec; 22(24):19-24. PubMed ID: 248923
    [No Abstract]   [Full Text] [Related]  

  • 42. [Short term care of morphine addicts].
    Tunving K
    Lakartidningen; 1977 Nov; 74(48):4312-5. PubMed ID: 592918
    [No Abstract]   [Full Text] [Related]  

  • 43. Suppression of withdrawal symptoms by dynorphin in heroin addicts.
    Wen HL; Ho WK
    Eur J Pharmacol; 1982 Aug; 82(3-4):183-6. PubMed ID: 6127224
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comprehensive treatment for heroin addicts: a pilot study.
    Senay EC; Mehta C; Dorus W; Soberij K; Baumgardner M
    J Psychoactive Drugs; 1986; 18(2):107-16. PubMed ID: 3734953
    [No Abstract]   [Full Text] [Related]  

  • 45. Three therapeutic communities. A prospective controlled study of narcotic addiction treatment: process and two-year follow-up results.
    Bale RN; Zarcone VP; Van Stone WW; Kuldau JM; Engelsing TM; Elashoff RM
    Arch Gen Psychiatry; 1984 Feb; 41(2):185-91. PubMed ID: 6365016
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Temporal patterns of drug use by heroin addicts.
    Sinnett ER; Judd B; Rissman K; Harvey WM
    Int J Addict; 1980 Nov; 15(8):1241-8. PubMed ID: 6971270
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Type of hospital setting and treatment outcome with heroin addicts. Results from a randomised trial.
    Strang J; Marks I; Dawe S; Powell J; Gossop M; Richards D; Gray J
    Br J Psychiatry; 1997 Oct; 171():335-9. PubMed ID: 9373421
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dynamics of assessments of time intervals by patients with heroin addiction.
    Aleksandrov SG
    Neurosci Behav Physiol; 2005 May; 35(4):371-4. PubMed ID: 15929562
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Addicts on parole: short-term and long-term prognosis.
    Bailey WC
    Int J Addict; 1975; 10(3):417-31. PubMed ID: 1176222
    [No Abstract]   [Full Text] [Related]  

  • 50. Withdrawal syndrome after guanabenz.
    Walker BR; Geczy M
    J Clin Pharmacol; 1980 Jan; 20(1):69-70. PubMed ID: 7358870
    [No Abstract]   [Full Text] [Related]  

  • 51. An investigation of the feasibility of predicting outcome indices in the treatment of heroid addiction.
    Sirotnik KA; Roffe MW
    Int J Addict; 1977 Sep; 12(6):755-75. PubMed ID: 591136
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Death of Fernand Widal.
    Am J Public Health Nations Health; 1929 Apr; 19(4):415-6. PubMed ID: 18012726
    [No Abstract]   [Full Text] [Related]  

  • 53. Professor Fernand Widal.
    Can Med Assoc J; 1929 Mar; 20(3):298. PubMed ID: 20317266
    [No Abstract]   [Full Text] [Related]  

  • 54. FERNAND WIDAL, M.D.
    Br Med J; 1929 Jan; 1(3550):134-5. PubMed ID: 20774409
    [No Abstract]   [Full Text] [Related]  

  • 55. [Comparative effectiveness of alpha-2 adrenergic agonists (clonidine-guanfacine) in the hospital detoxification of opiate addicts].
    Muga R; Tor J; Forteza-Rei J; Jacas C; Altés J; Mestre L
    Med Clin (Barc); 1990 Feb; 94(5):169-72. PubMed ID: 1969980
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiovascular parameters of heroin-withdrawn addicts treated with guanfacine.
    Rubio G; Alguacil LF; Alamo C; López-Muñoz F; Pascual J; López-Trabada JR
    Methods Find Exp Clin Pharmacol; 1997 Apr; 19(3):189-92. PubMed ID: 9203168
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of heroin withdrawal with guanfacine: an open clinical investigation.
    Soler Insa PA; Bedate Villar J; Theohar C; Yotis A
    Can J Psychiatry; 1987 Nov; 32(8):679-82. PubMed ID: 2891431
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of clonidine, guanfacine and methadone in the rapid detoxification of heroin addicts: a controlled clinical trial.
    San L; Camí J; Peri JM; Mata R; Porta M
    Br J Addict; 1990 Jan; 85(1):141-7. PubMed ID: 1968773
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Use of presynaptic alpha-mimetics for withdrawal in heroin addicts].
    Gorceix A; Dugarin J; Pommier F
    Ann Med Interne (Paris); 1985; 136(5):389-92. PubMed ID: 2865924
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.